Provided by Tiger Trade Technology Pte. Ltd.

Kairos Acquisition Corp.

10.08
0.0000
Volume:- -
Turnover:- -
Market Cap:347.59M
PE:26.48
High:10.08
Open:10.08
Low:10.08
Close:10.08
52wk High:10.08
52wk Low:9.71
Shares:34.50M
Float Shares:19.42M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3805
EPS(LYR):0.2432
ROE:--
ROA:-0.96%
PB:-33.11
PE(LYR):41.43

Loading ...

Kairos Minerals Advances Mt York Gold Project

TIPRANKS
·
Oct 22, 2025

Kairos Pharma Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Oct 20, 2025

Kairos Minerals Announces Significant Securities Issue

TIPRANKS
·
Oct 15, 2025

Kairos Minerals Secures A$27M to Advance Gold Projects

TIPRANKS
·
Oct 15, 2025

Analysts Have Conflicting Sentiments on These Materials Companies: Kingsgate Consolidated Limited (OtherKSKGF), Evolution Mining (OtherCAHPF) and Kairos Minerals (OtherKAIFF)

TIPRANKS
·
Oct 13, 2025

Kairos Minerals Signs Mineral Rights Agreement With Pilbara Minerals; Shares Down 7%

MT Newswires Live
·
Oct 10, 2025

Promising Developments in Kairos Pharma’s Lead Candidate ENV-105 Drive Buy Rating

TIPRANKS
·
Oct 09, 2025

Kairos Pharma Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Oct 07, 2025

Kairos Pharma to Present at ESMO Congress 2025

TIPRANKS
·
Oct 07, 2025

Kairos Minerals Extends Gold Mineralization at Mt York Project

TIPRANKS
·
Oct 07, 2025

EZZ Life Science Holdings And 2 Other Promising ASX Penny Stocks

Simply Wall St.
·
Oct 03, 2025

Fosun Pharma Unit's Registration Application for Leukemia Drug Accepted in China

MT Newswires Live
·
Sep 24, 2025

Global Lithium Sells Stake in Kairos Minerals to Bolster Manna Project

TIPRANKS
·
Sep 22, 2025

Kairos Pharma Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Sep 19, 2025

Kairos Pharma Reports Positive Phase 2 Trial Results

TIPRANKS
·
Sep 18, 2025

Kairos Pharma’s Promising Developments and Positive Trial Data Reinforce Buy Recommendation

TIPRANKS
·
Sep 18, 2025